SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-143369
Filing Date
2024-05-21
Accepted
2024-05-21 08:29:32
Documents
13
Period of Report
2024-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d773656d8k.htm   iXBRL 8-K 28323
  Complete submission text file 0001193125-24-143369.txt   152406

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA anro-20240521.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE anro-20240521_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anro-20240521_pre.xml EX-101.PRE 11276
16 EXTRACTED XBRL INSTANCE DOCUMENT d773656d8k_htm.xml XML 3638
Mailing Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022
Business Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

IRS No.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 24966913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)